Skip to content

Lung Transplantation in Respiratory Failure Patients

Extracorporeal Membrane Oxygenation Support for Bilateral Sequential Lung Transplantation in Respiratory Failure Patients.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00854165
Enrollment
10
Registered
2009-03-03
Start date
2009-02-28
Completion date
2009-06-30
Last updated
2009-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Failure

Keywords

lung transplantation, respiratory failure, ECMO, Lung transplants in respiratory failure patients

Brief summary

Survival after cadaveric lung transplantation in recipients depended on ventilation support prior to transplantation has been reported to have relative high surgical mortality and morbidity rate. The objectives of this study were to describe the short-term outcomes of bilateral sequential lung transplantation under extracorporeal membrane oxygenation (ECMO) support in a consecutive series of patients who depended on noninvasive and invasive ventilation support preoperatively .

Detailed description

The one-year survival rate and postoperative pulmonary functional results will be reported in this study.

Interventions

None listed

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* respiratory patients depended on ventilator supports prior to lung transplant

Exclusion criteria

* non-cardaveric lung transplant

Design outcomes

Primary

MeasureTime frame
6 months and one year survival after lung transplatn.6 months and one year posttransplant

Secondary

MeasureTime frame
Pulmonary function results, at baseline and posttransplant 1, 3, and 6 months.baseline, post-op 1,3, and 6 months

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026